+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Self-injections Market by Type, Usage, Distribution Channel, Therapeutic Areas Application - Global Forecast 2025-2030- Product Image
Self-injections Market by Type, Usage, Distribution Channel, Therapeutic Areas Application - Global Forecast 2025-2030- Product Image
Sale

Self-injections Market by Type, Usage, Distribution Channel, Therapeutic Areas Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4985960
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Self-injections Market grew from USD 54.00 billion in 2023 to USD 60.64 billion in 2024. It is expected to continue growing at a CAGR of 12.72%, reaching USD 124.87 billion by 2030.

Self-injections encompass medical devices and pharmaceuticals allowing patients to administer medication independently, critical for chronic diseases or conditions requiring frequent dosing, such as diabetes, rheumatoid arthritis, and auto-immune disorders. The necessity for self-injections is driven by the need to enhance patient compliance, reduce healthcare costs, and provide convenience, particularly in aging populations and those preferring home-based care. Applications of self-injections span insulin delivery for diabetics, hormones for endocrine disorders, and biologics for immune-mediated diseases. End-users predominantly include patients, home care settings, and healthcare facilities that train patients for self-administration.

Market growth is influenced by rising chronic disease prevalence, advancements in biologics, and innovations in drug delivery systems focusing on user-friendliness. The latest potential opportunities lie in developing smart autoinjectors with connectivity features, expanding into emerging markets where underpenetration persists, and targeting personalized medicine solutions that cater to individual needs. To capitalize on these, companies should focus on patient-centric design, affordability, and education and training initiatives for both patients and healthcare providers. However, market limitations include high device costs, stringent regulatory standards, and needle phobia, which may deter use. Additionally, disparities in access to technology and lack of awareness in certain regions pose challenges to market penetration.

Innovation areas ripe for exploration include wearable technologies for continuous drug delivery, AI-powered adherence monitoring, and formulation advancements for stabilizing biologics at room temperature. The market remains competitive, emphasizing the need for strategic collaborations with healthcare providers and leveraging digital health to improve patient engagement and outcomes. Despite challenges, the self-injection market holds substantial growth potential by aligning technological advancements with evolving healthcare needs and patient preferences, thereby paving pathways for sustainable business growth through innovation and strategic expansion.

Understanding Market Dynamics in the Self-injections Market

The Self-injections Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rapid prevalence of chronic diseases and rheumatoid arthritis
    • Wide availability of self-injections for fertility treatments
  • Market Restraints
    • Potential risk of product recall
  • Market Opportunities
    • Ongoing government approvals for self-injections worldwide
    • Technological advancements in self-injection devices
  • Market Challenges
    • Limited awareness and administration challenges associated with self-injections

Exploring Porter’s Five Forces for the Self-injections Market

Porter’s Five Forces framework further strengthens the insights of the Self-injections Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Self-injections Market

External macro-environmental factors deeply influence the performance of the Self-injections Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Self-injections Market

The Self-injections Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Self-injections Market

The Self-injections Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Self-injections Market, highlighting leading vendors and their innovative profiles. These include Insulet Corporation, Johnson & Johnson Services, Inc., SCHOTT AG, Eli Lilly and Company, AstraZeneca plc, PharmaJet, Inc., West Pharmaceutical Services, Inc., Teva Pharmaceutical Industries Ltd., Terumo Corporation, Enable Injections, Inc., Owen Mumford Limited, SHL Medical AG, Merck KGaA, Sanofi S.A., Recipharm AB, DALI Medical Devices Ltd., Credence MedSystems, Inc., Novo Nordisk A/S, Mylan N.V. by Viatris Inc., GlaxoSmithKline plc, Gerresheimer AG, Medmix AG by Sulzer Ltd., Molex LLC by Koch Industries, Inc., PenJet Corporation, Ypsomed Group, Baxter International, Inc., Pfizer Inc., Becton, Dickinson and Company, Antares Pharma, Inc. by Halozyme, Inc., and AbbVie Inc..

Market Segmentation & Coverage

This research report categorizes the Self-injections Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Auto-Injectors
    • Needle-free Injectors
    • Pen Injectors
    • Wearable Injectors
  • Usage
    • Disposable
    • Reusable
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Private Clinics
  • Therapeutic Areas Application
    • Autoimmune Diseases
      • AIDS
      • Allergies
      • Cancer
      • Irritable Bowel Disorders
      • Multiple Sclerosis
      • Psoriasis
    • Emergency Drugs
      • Anaphylactic Socks
      • Migraine
    • Hormone Replacement Therapies
      • Beta-Interferon
      • Erythropoietin
      • Follicle Stimulating Hormone
      • Heparin
      • Insulin
      • Parathyroid Hormone
      • Parkinson’s
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid prevalence of chronic diseases and rheumatoid arthritis
5.1.1.2. Wide availability of self-injections for fertility treatments
5.1.2. Restraints
5.1.2.1. Potential risk of product recall
5.1.3. Opportunities
5.1.3.1. Ongoing government approvals for self-injections worldwide
5.1.3.2. Technological advancements in self-injection devices
5.1.4. Challenges
5.1.4.1. Limited awareness and administration challenges associated with self-injections
5.2. Market Segmentation Analysis
5.2.1. Type: Rising preference for pen injectors to manage chronic diseases
5.2.2. Usage: Growing use of disposable self-injections to avoid the risk of cross-contamination
5.2.3. Distribution Channel: Emerging penetration of self-injections on online platforms
5.2.4. Therapeutic Areas Application: Growing applications of self-injections to treat hormonal issues
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Self-injections Market, by Type
6.1. Introduction
6.2. Auto-Injectors
6.3. Needle-free Injectors
6.4. Pen Injectors
6.5. Wearable Injectors
7. Self-injections Market, by Usage
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Self-injections Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Private Clinics
9. Self-injections Market, by Therapeutic Areas Application
9.1. Introduction
9.2. Autoimmune Diseases
9.2.1. AIDS
9.2.2. Allergies
9.2.3. Cancer
9.2.4. Irritable Bowel Disorders
9.2.5. Multiple Sclerosis
9.2.6. Psoriasis
9.3. Emergency Drugs
9.3.1. Anaphylactic Socks
9.3.2. Migraine
9.4. Hormone Replacement Therapies
9.4.1. Beta-Interferon
9.4.2. Erythropoietin
9.4.3. Follicle Stimulating Hormone
9.4.4. Heparin
9.4.5. Insulin
9.4.6. Parathyroid Hormone
9.4.7. Parkinson’s
10. Americas Self-injections Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Self-injections Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Self-injections Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Micron Biomedical Receives Funds To Produce Needle-Free Vaccines
13.3.2. Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
13.3.3. Altaviz introduces New Auto-Injector Platform For Drug Delivery
13.3.4. FDA Approves On-Body Injector for Self Administration of Pegcetacoplan for PNH
13.3.5. Civica Partners With Ypsomed For Insulin Injection Pen
13.3.6. Eitan Medical Completes Transition of Wearable Injectors Business
13.3.7. Coherus Announces U.S. Launch of UDENYCA Autoinjector
13.3.8. Ypsomed Enhances Self-Injection Device Platforms With Integrated Human Factors Services
13.3.9. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
13.3.10. US FDA Approves Tezspire For Self-Administration Using Pre-Filled Pen
13.3.11. Phillips-Medisize Expands Product Portfolio with Launch of a Pen Injector Platform Designed to Lower Pharma Costs, Risks and Market Barriers
List of Figures
FIGURE 1. SELF-INJECTIONS MARKET RESEARCH PROCESS
FIGURE 2. SELF-INJECTIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SELF-INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SELF-INJECTIONS MARKET DYNAMICS
TABLE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON’S, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 63. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 65. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CANADA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 68. CANADA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 69. CANADA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. MEXICO SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MEXICO SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 75. MEXICO SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 100. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 102. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. CHINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CHINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 105. CHINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 106. CHINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 107. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 109. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. INDIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. INDIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 112. INDIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 113. INDIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 121. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 123. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. JAPAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. JAPAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 126. JAPAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 127. JAPAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 147. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 154. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 155. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 161. TAIWAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 162. TAIWAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 163. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 165. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. THAILAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. THAILAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 168. THAILAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 169. THAILAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 175. VIETNAM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 176. VIETNAM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 185. DENMARK SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. DENMARK SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 187. DENMARK SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. DENMARK SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. DENMARK SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 190. DENMARK SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. DENMARK SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 192. EGYPT SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 194. EGYPT SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. EGYPT SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. EGYPT SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 197. EGYPT SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 198. EGYPT SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 199. FINLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 201. FINLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. FINLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. FINLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 204. FINLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 205. FINLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. FRANCE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 208. FRANCE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. FRANCE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. FRANCE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 211. FRANCE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 212. FRANCE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 213. GERMANY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. GERMANY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 215. GERMANY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. GERMANY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. GERMANY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 218. GERMANY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 219. GERMANY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 225. ISRAEL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 227. ITALY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. ITALY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 229. ITALY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. ITALY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ITALY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 232. ITALY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 233. ITALY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 248. NORWAY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. NORWAY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 250. NORWAY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. NORWAY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. NORWAY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 253. NORWAY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 254. NORWAY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 255. POLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. POLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 257. POLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. POLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. POLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 260. POLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 261. POLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 262. QATAR SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. QATAR SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 264. QATAR SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. QATAR SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. QATAR SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 267. QATAR SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 268. QATAR SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 290. SPAIN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 291. SPAIN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 292. SPAIN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. SPAIN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SPAIN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 295. SPAIN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 296. SPAIN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 309. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 310. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 311. TURKEY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. TURKEY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 313. TURKEY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. TURKEY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. TURKEY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 316. TURKEY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 317. TURKEY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 330. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 332. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 333. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Self-injections market, which are profiled in this report, include:
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • SCHOTT AG
  • Eli Lilly and Company
  • AstraZeneca plc
  • PharmaJet, Inc.
  • West Pharmaceutical Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Terumo Corporation
  • Enable Injections, Inc.
  • Owen Mumford Limited
  • SHL Medical AG
  • Merck KGaA
  • Sanofi S.A.
  • Recipharm AB
  • DALI Medical Devices Ltd.
  • Credence MedSystems, Inc.
  • Novo Nordisk A/S
  • Mylan N.V. by Viatris Inc.
  • GlaxoSmithKline plc
  • Gerresheimer AG
  • Medmix AG by Sulzer Ltd.
  • Molex LLC by Koch Industries, Inc.
  • PenJet Corporation
  • Ypsomed Group
  • Baxter International, Inc.
  • Pfizer Inc.
  • Becton, Dickinson and Company
  • Antares Pharma, Inc. by Halozyme, Inc.
  • AbbVie Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 60.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 124.87 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Self-injection Devices Market Size, Share & Trends Analysis By Product (Auto Injectors, Pen Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Self-injection Devices Market Size, Share & Trends Analysis By Product (Auto Injectors, Pen Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Injectable Drugs Market by Molecule Type, Drug Class, Injection Routes, Application - Global Forecast 2025-2030 - Product Image

Injectable Drugs Market by Molecule Type, Drug Class, Injection Routes, Application - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Self-Injections Global Market Report 2024 - Product Image

Self-Injections Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, Obesity, Fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030 - Product Image

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, Obesity, Fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030

  • Report
  • 243 Pages
  • Global
From
Global Self-injection Devices Market by Product, by Usability, by Application, by Distribution Channel, and By Region - Product Image

Global Self-injection Devices Market by Product, by Usability, by Application, by Distribution Channel, and By Region

  • Report
  • 200 Pages
  • Global
From

About the Self Injectable Device Market

The Self Injectable Device market is a subset of the Home Testing and Home Healthcare industry. It includes products such as auto-injectors, pre-filled syringes, and pen injectors, which are used to deliver medications to patients in their own homes. These devices are designed to be easy to use and provide accurate dosing, allowing patients to self-administer their medications without the need for a healthcare professional. Self Injectable Devices are becoming increasingly popular due to their convenience and cost-effectiveness. The Self Injectable Device market is highly competitive, with a number of companies offering products for a variety of medical conditions. Some of the major players in the market include Becton Dickinson, Novo Nordisk, Sanofi, Eli Lilly, and Pfizer. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.